COMMON STOCK PURCHASE WARRANT Bolt Projects Holdings, Inc.Common Stock Purchase Warrant • February 14th, 2025 • Bolt Projects Holdings, Inc. • Industrial organic chemicals • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the common stock purchase agreement, dated February 12, 2025 (the “Agreement”) by and between Bolt Projects Holdings, Inc., a Delaware corporation (the “Company”) and TRITON FUNDS LP (the “Investor” and including any permitted and registered assigns, the “Holder”), the Holder is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period (as defined below), to purchase from the Company, up to $1,500,000 of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof.
COMMON STOCK PURCHASE WARRANT PRECISION THERAPEUTICS INC.Common Stock Purchase Warrant • November 16th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, the Holder (as defined below), [NAME OF HOLDER] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 3, 2019 (“Issuance Date”), to purchase from Precision Therapeutics Inc., a Delaware corporation (the “Company”), up to [______________] shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price (defined below) per share then in effect. This Warrant is one of the Warrants (the “Warrants”) issued pursuant to the Warrant Agency Agreement, dated as of April 3, 2019, by and between the Company and Corporate Stock Transfer, Inc. (the “Warrant Agent”) (the “Warrant Agency Agreement”) in connection with the exchange offer to holders of warrants of Helomics Holding Corporation.